| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00098787 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2013-11-01 | |
| P921 | main subject | rectum adenocarcinoma | Q18554959 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 247 | |
| P4844 | research intervention | fluorouracil | Q238512 |
| irinotecan | Q412197 | ||
| calcium oxalate | Q412399 | ||
| bevacizumab | Q413299 | ||
| leucovorin calcium | Q27077063 | ||
| P6153 | research site | Creighton University | Q770544 |
| Case Western Reserve University | Q1047060 | ||
| Indiana University – Purdue University Indianapolis | Q1433199 | ||
| AdventHealth Porter | Q3145247 | ||
| Bryn Mawr Hospital | Q4980899 | ||
| Grady Memorial Hospital | Q5592136 | ||
| Swedish Medical Center | Q7654755 | ||
| MetroHealth Medical Center | Q30254005 | ||
| Metro-Minnesota Community Oncology Research Consortium | Q30269543 | ||
| Sky Ridge Medical Center | Q30270451 | ||
| Park Nicollet Methodist Hospital | Q30281210 | ||
| West Michigan Cancer Center | Q30289179 | ||
| Elkhart General Hospital | Q87932226 | ||
| P580 | start time | 2005-07-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer |
Search more.